The Mental Health Mission’s (MHM) Capacity Development workstream is inviting applications from researchers employed by or connected to the MHM for industry internship funding. The Industry Internships Funding Programme aims…
The MHM has partnered with the NIHR Incubator for Mental Health Research to offer the GROW programme, a bespoke career development programme open to and designed for MHM early career…
Tim Nicholls, who recently joined the MHM as Implementation Lead, said he was left “optimistic about the work being carried out” after a visit to the Mental Health Research for…
Colleagues from Oxford Health Research & Development team are attending the International Mental Health Nursing Research Conference, a knowledge sharing event dedicated to research in mental health nursing. Debbie Moll,…
This week, a product licence for the medicine lecanemab (Leqembi) was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adult patients in the early stages of…
Research supported by University of Oxford’s Department of Experimental Psychology Prof. Anke Ehlers, Theme Lead of the BRC’s Psychological Treatments Theme, has found that the type of coping strategy used…
Oxford Health research staff will be attending the Autumn Information Fayre on Wednesday 4 September at the Windmill Centre in Deddington to provide information on dementia research taking place in…
The Mental Health Mission’s Capacity Development (CD) workstream have recently published a report on barriers and enablers to mental health research in the UK, led by Aiste Adomaviciene, Project Manager…
Oxford will host the first conference of its kind into body-focused repetitive behaviours (BFRBs) such as hair pulling and skin picking next month. It comes just over a year after…
A prescription treatment for insomnia developed by Big Health has received US Food and Drug Administration (FDA) approval this week. Big Health joint co-founder University of Oxford’s Prof Colin Espie…
Increasing serotonin can change how people learn from negative information, as well as improving how they respond to it, according to a new study published in the leading journal Nature…
The largest ever trial to investigate whether ketamine-assisted therapy could help people with alcohol problems stop drinking is now recruiting participants. The first patients are being screened to see if…
In a new paper published today in BJPsych it is suggested that a specific anti constipation drug, prucalopride may reduce the risk of experiencing depression in individuals with no past…
New figures show more than 5,000 people from Buckinghamshire participated in trials in the 12 months from April 2023, including those run at Oxford Health NHS Foundation Trust. They took…
Many people who were hospitalised with COVID-19 continue to have cognitive and psychiatric problems even two to three years post-infection, according to a new study published today in Lancet Psychiatry….